NYSE
Regeneron Pharmaceuticals
$193.82
+4.66 (2.46%)
Offline
Bull Bear Scale
REGN
56
score
Price action
193.82
+4.66 (+2.46%)1D
Market closed · Fri, Sep 18, 9:30 AM–4:00 PM ET
Click and drag to measure a move.Use two fingers to measure a move.
Reconnecting…
No messages yet
Say hi to everyone on Bull or Bear.
Live P&L tape
Real fills on REGN with cost-basis gains & losses
Offline
Your vote
One call per vote type per day — tap again to clear, or the other side to flip. Free accounts get 5 new calls/day across the app.
Sentiment desk
Crowd pulse, competing narratives, split news, and labeled street takes — so you can weigh bull and bear without leaving the page.
Our data
56
Crowd lean and tape are rhyming — conviction feels cleaner.
Desk signals
Crowd and tape both lean bull — confirmation, not a free lunch.
56% bull · 44% bear
Contest heat
Knife fight
Street mix
Street mixed
Vote fuel
Quiet room
Living narrative
Two briefs that rotate as the day’s story shifts — not a single merged take.
Bulls say
The bull case treats pullbacks as inventory to absorb — structure intact, buyers still showing up on weakness.
Updates with today’s narrative
Bears say
Cautious framing: narrative got ahead of price. They’re waiting for a clean break, not shorting noise.
Updates with today’s narrative
Split view
Scroll each column on its own so you can compare framing side by side.
Bull-framed
Street note: upside skew still favors Regeneron Pharmaceuticals
Call-side notes argue the crowd is early, not wrong — so long as price respects the recent base.
REGN: constructive base, bulls keep the benefit of the doubt
Call-side notes argue the crowd is early, not wrong — so long as price respects the recent base.
Options flow: call interest rebuilding in REGN
Writers highlight defended levels and improving relative strength — classic “buy the dip, don’t chase the spike” tone.
Why dip-buyers still want REGN on weakness
Writers highlight defended levels and improving relative strength — classic “buy the dip, don’t chase the spike” tone.
Positioning check — REGN longs not as crowded as the timeline
Writers highlight defended levels and improving relative strength — classic “buy the dip, don’t chase the spike” tone.
Bear-framed
Supply check: who is selling REGN into strength?
Risk notes flag stretched multiples and a tape that still needs a cleaner break to flip the lean.
Regeneron Pharmaceuticals — failed breakout risk still on the table
Bear briefs stress distribution tells and soft follow-through — green prints as liquidity, not confirmation.
Put buyers quietly rebuilding in REGN
Put-side framing: wait for confirmation. Until then, strength is for trimming, not adding.
REGN bounce looks fragile — bears want lower highs
Risk notes flag stretched multiples and a tape that still needs a cleaner break to flip the lean.
Valuation overhang: the case against chasing Regeneron Pharmaceuticals
Bear briefs stress distribution tells and soft follow-through — green prints as liquidity, not confirmation.
Cashtag chatter
Demo feed
Short takes labeled bull or bear. Demo stream until a live social feed is connected.
If $REGN holds this shelf, bulls stay in control.
Not short yet on $REGN — waiting for the break, not the headline.
Valuation + soft follow-through. $REGN still a fade for me.
If $REGN holds this shelf, bulls stay in control.
If $REGN holds this shelf, bulls stay in control.
Lower high forming in $REGN. Patience > FOMO.
$REGN bounce = exit liquidity until proven otherwise.
Adding a starter in $REGN — want follow-through, not hopium.
Relative strength in $REGN vs peers is the tell.
If $REGN holds this shelf, bulls stay in control.
Still long $REGN. Weak opens = inventory.
Lower high forming in $REGN. Patience > FOMO.
Crowd is noisy but the tape in $REGN is cleaner than Twitter.
Crowded long narrative in $REGN. That’s the risk.
Mock profile for REGN used for swipe and chart demos.
Bull or Bear は娯楽と議論のためのものです——投資助言ではありません。 利用規約 · プライバシー · Safety. 相場はシミュレーションまたは遅延の場合があります。
